Same molecule as Wegovy®.
Semaglutide docks into the GLP-1 receptor on the cell membrane — the same lock the brand-name drug binds — quieting the hunger signal and slowing digestion so you feel full sooner.

The
You inject from a vial with a small syringe instead of a pre-filled pen. Same medicine, lower price, no insurance paperwork.
Active: semaglutide, titrated from a 0.25 mg starting dose up to a clinically appropriate maintenance dose.
Excipients: sodium chloride, water for injection, and a sterile buffer system standard to injectable preparations.
Pharmacy: a U.S.-licensed 503A compounding pharmacy operating in an FDA-registered facility. Compounded preparations are not FDA-approved as finished products.
Draw your dose and inject
Your provider increases the dose every 4 weeks based on tolerance and progress — mirroring the branded titration protocol.
Semaglutide docks into the GLP-1 receptor on the cell membrane — the same lock the brand-name drug binds — quieting the hunger signal and slowing digestion so you feel full sooner.
In STEP-1, semaglutide 2.4 mg produced an average ~14.9% body-weight reduction at 68 weeks — placebo landed near ~2.4%. Trial data is on the molecule; compounded preparations are not separately trialed.*
Pay $249/mo month-to-month, or lock the 52-week commit at $179/mo — that’s $70 less every month, $840 less every year. Cash pay, no insurer back-and-forth.

Join Teledris — $59/mo membership covers care, messaging, and dose adjustments. Cancel anytime.
Medication cost not included.A licensed U.S. provider reviews your intake and decides whether semaglutide is the right call for you. Most days, under 24 hours.
If prescribed, you get a tailored titration schedule — starting dose, step-up cadence, and side-effect support. Cash pay, no insurer paperwork.
From prescription to your door in days, refrigerated. Cold-chain overnight where available. Refills auto-renew.


What you get with Teledris:
Compounded · 503A
Semaglutide acts on the GLP-1 receptor to quiet appetite and slow digestion — so you feel full sooner and stay full longer. Compounded in the U.S. at a fraction of branded retail. Cash or insurance — your call.
Pricing
Membership required ($59/mo, cancel anytime). Medication billed separately at the tier you select. Coaching is bundled — already inside the price you see.
Both deliver the same active ingredient. The weekly injection has the longest clinical track record. The daily pill skips the needle and the fridge.
Find my fit*An active Teledris membership is required ($59/mo, cancel anytime). Total cost includes the standard monthly membership fee and, if prescribed, the cost of medication. Membership and medication are billed separately. A prescription is not guaranteed. Medication is not available without an active membership.


1 SELECT trial: in adults with established cardiovascular disease and overweight or obesity, semaglutide 2.4 mg reduced major adverse cardiovascular events vs placebo. Compounded preparations are not separately trialed; talk to your provider.

It is prepared in a U.S.-licensed 503A compounding pharmacy operating in an FDA-registered, state-licensed facility. A licensed provider reviews your intake first and only prescribes if semaglutide is the right call for you. Compounded preparations are not FDA-approved as finished products.
The active molecule is identical — semaglutide, the same GLP-1 receptor agonist.
The differences are commercial. Wegovy® is branded and ships as a pre-filled pen. Compounded semaglutide ships as a vial-and-syringe kit from $179/mo cash. Compounded preparations are not FDA-approved as finished products.
The clinical evidence — STEP-1 and the broader STEP program — is on the semaglutide molecule, and the molecule is the same in both preparations. Compounded versions are not separately trialed, so your provider tailors the titration to mirror the branded protocol.
No. It is cash pay — $249/mo month-to-month, or $179/mo on a 52-week commit. No prior auths, no insurer paperwork. If your insurance ever covers branded Wegovy, we can switch you to the branded pen.
Roughly 16 weeks to reach a typical maintenance dose. Most patients start at 0.25 mg and step up every 4 weeks under provider guidance, mirroring the branded protocol. Your provider may move faster or slower based on how your body responds.
Store the vial refrigerated (36–46°F / 2–8°C) until use. Do not freeze. Shipments arrive in insulated cold-chain packaging — refrigerate immediately on arrival.
Once in use, follow your provider and pharmacy guidance on beyond-use dating. Never use a vial that has been frozen, left at room temperature for an extended stretch, or looks cloudy or discolored.
Adults 18+ in eligible states with a BMI of 30+, or 27+ with a weight-related condition. A licensed provider reviews your full intake and medical history to decide if semaglutide is the right fit for you.
Florida, Texas, and California today. More states are rolling out through the year. If we are not in yours yet, leave your email and we will tell you the day we are.
The most common side effects are gastrointestinal — nausea, mild diarrhea, constipation, and reduced appetite — and most ease as the body adjusts. Slow titration is designed to minimize them.
Message your provider through the app whenever you need to. Care messaging is included in the $59/mo membership, with 24/7 access for urgent questions.
GLP-1s are intended for long-term use. When the medication stops, the appetite signals it was suppressing can return and weight regain is common. Always talk to your provider before stopping or pausing.